Combination of gambogic acid with cisplatin enhances the antitumor effects on cisplatin-resistant lung cancer cells by downregulating MRP2 and LRP expression

Combination of gambogic acid with cisplatin enhances the antitumor effects on cisplatin-resistant lung cancer cells by downregulating MRP2 and LRP expression

Wendian Zhang,* Hechao Zhou,* Ying Yu,* Jingjing Li, Haiwen Li, Danxian Jiang, Zihong Chen, Donghong Yang, Zumin Xu, Zhonghua Yu Cancer Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong Province, People’s Republic of China *These authors contributed equall...

Full description

Bibliographic Details
Main Authors: Zhang W, Zhou H, Yu Y, Li J, Li H, Jiang D, Chen Z, Yang D, Xu Z, Yu Z
Format: Article
Language:English
Published: Dove Medical Press 2016-06-01
Series:OncoTargets and Therapy
Subjects:
Gambogic acid
Cisplatin
Drug resistance
Lung neoplasms
Major vault protein
Multidrug resistance-associated protein 2
Online Access:https://www.dovepress.com/combination-of-gambogic-acid-with-cisplatin-enhances-the-antitumor-eff-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/combination-of-gambogic-acid-with-cisplatin-enhances-the-antitumor-eff-peer-reviewed-article-OTT

Similar Items